STONKWHISPER
← Back to Intel
Insider ActivityTERN

Gengos Andrew, Chief Financial Officer at Terns Pharmaceuticals, Inc., traded $3.6M of TERN

Updated Jun 14, 2026
Gengos Andrew Chief Financial Officer
Terns Pharmaceuticals, Inc. · $TERN
$3.6M Total Value
68,750 Shares Traded
$53 Price / Share
Shares Owned After
2026-05-05 Filing Date

Transaction Details

InsiderGengos Andrew
TitleChief Financial Officer
CompanyTerns Pharmaceuticals, Inc.
TickerTERN
Transaction TypeDisposition
Transaction Date2026-05-05
Shares Traded68,750
Price Per Share$53
Total Value$3.6M
Filed Date2026-05-05
Accession Number0001563623-26-000004

Ownership Context

Shares Owned After Transaction
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001563623-26-000004

Other Insider Trades — TERN

Other Trades by Gengos Andrew

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for TERN — Terns Pharmaceuticals, Inc. →

Whisper Score — TERN

29.91
Murmurs
Current Whisper Score

See full analysis for TERN →

Track TERN insider activity in real time on The Wire →

Get alerts when Gengos Andrew files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 14, 2026 at 07:13 UTC

Want real-time data? Access The Wire for live sentiment tracking.